Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Metmore-G1 Tablet PR

Prescription Icon
Prescription Required

Marketer

Morepen Laboratories Ltd

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Metmore-G1 Tablet PR

GlucoTwin-DX tablets are antidiabetic medications combining two active ingredients for adult type 2 diabetes management. They regulate blood sugar levels. Take GlucoTwin-DX with meals, consistently at the same time daily for optimal effect. Dosage is determined by your physician and may adjust based on your blood glucose readings. Continuous use is crucial; discontinuation without medical supervision risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan, encompassing diet, exercise, and weight control as directed by your doctor. Lifestyle significantly impacts diabetes control. Hypoglycemia (low blood sugar) is a common side effect. Learn to recognize symptoms like sweating, lightheadedness, headache, and tremors, and know how to treat them. Maintain regular meals and carry a fast-acting glucose source (e.g., sugary snacks, juice). Alcohol increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. Do not use GlucoTwin-DX if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney/liver impairment. Inform your doctor of any heart history before starting treatment. Pregnant or breastfeeding individuals should consult their physician prior to use. Regular blood sugar monitoring is necessary, along with potential blood tests for blood cell counts and liver function.

Uses of Metmore-G1 Tablet PR

Managing type 2 diabetes

Major Benefits of Metmore-G1 Tablet PR:

Follow your physician's instructions or consult the product label for usage guidelines. Administer Metmore-G1 Tablet PR with a meal.

Common Side effects of Metmore-G1 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Metmore-G1 Tablet PR:

Follow your physician's instructions or consult the product label for proper administration. Take Metmore-G1 Tablet PR with meals.

How Metmore-G1 Tablet PR works:

Metmore-G1 Tablet PR combines glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Metmore-G1 Tablet PR is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Employing Metmore-G1 Tablet PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation is contraindicated for patients using Metmore-G1 Tablet PR due to potential infant toxicity.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Metmore-G1 Tablet PR cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates its use. Consult a physician. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Metmore-G1 Tablet PR cautiously, potentially requiring dosage modification. Consult a physician. A low initial dose is typically recommended for individuals with mild to moderate liver disease; Metmore-G1 Tablet PR is contraindicated in those with severe hepatic dysfunction.

What if you forget to take Metmore-G1 Tablet PR :

Should you forget a dose of Metmore-G1 Tablet PR, administer it at your earliest convenience. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Metmore-G1 Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Metmore-G1 Tablet PR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it remains inaccessible to children, pets, and others.
Metmore-G1 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA—Metformin-associated lactic acidosis). While rare, this harmful side effect is more likely in patients with kidney disease, older individuals, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Metmore-G1 Tablet PR and seek immediate medical attention.
Metmore-G1 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. This medication improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 DM.
Metmore-G1 Tablet PR may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Metmore-G1 Tablet PR use can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness), urinary issues, cognitive changes, and balance problems (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Metmore-G1 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Consuming alcohol while taking Metmore-G1 Tablet PR is unsafe. This combination can lower blood sugar, causing hypoglycemia, and increase the risk of lactic acidosis.
Metmore-G1 Tablet PR
38
MRP 44
12% off